FDA.reportPublic FDA data

Application 207240

Type
ANDA
Sponsor
SCIEGEN PHARMS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ARIPIPRAZOLEARIPIPRAZOLETABLET, ORALLY DISINTEGRATING;ORAL10MGNoNo
002ARIPIPRAZOLEARIPIPRAZOLETABLET, ORALLY DISINTEGRATING;ORAL15MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
43598-733AripiprazoleAripiprazole orally disintegratingDr. Reddy's Laboratories IncANDACurrent
43598-733AripiprazoleAripiprazole orally disintegratingDr. Reddy's Laboratories IncANDACurrent
43598-733AripiprazoleAripiprazole orally disintegratingDr. Reddy's Laboratories IncANDACurrent
43598-733AripiprazoleAripiprazole orally disintegratingDr. Reddy's Laboratories IncANDACurrent
43598-734AripiprazoleAripiprazole orally disintegratingDr. Reddy's Laboratories IncANDACurrent
43598-734AripiprazoleAripiprazole orally disintegratingDr. Reddy's Laboratories IncANDACurrent
43598-734AripiprazoleAripiprazole orally disintegratingDr. Reddy's Laboratories IncANDACurrent
43598-734AripiprazoleAripiprazole orally disintegratingDr. Reddy's Laboratories IncANDACurrent
50228-330AripiprazoleAripiprazole orally disintegratingScieGen Pharmaceuticals IncANDACurrent
50228-330AripiprazoleAripiprazole orally disintegratingScieGen Pharmaceuticals IncANDACurrent
50228-330AripiprazoleAripiprazole orally disintegratingScieGen Pharmaceuticals IncANDACurrent
50228-330AripiprazoleAripiprazole orally disintegratingScieGen Pharmaceuticals IncANDACurrent
50228-331AripiprazoleAripiprazole orally disintegratingScieGen Pharmaceuticals IncANDACurrent
50228-331AripiprazoleAripiprazole orally disintegratingScieGen Pharmaceuticals IncANDACurrent
50228-331AripiprazoleAripiprazole orally disintegratingScieGen Pharmaceuticals IncANDACurrent
50228-331AripiprazoleAripiprazole orally disintegratingScieGen Pharmaceuticals IncANDACurrent